Annual report pursuant to Section 13 and 15(d)

SELECTED FINANCIAL STATEMENT CAPTIONS - LIABILITIES (Details)

v3.20.4
SELECTED FINANCIAL STATEMENT CAPTIONS - LIABILITIES (Details) - USD ($)
$ in Thousands
Dec. 31, 2019
Sep. 30, 2019
Dec. 31, 2018
Accounts payable:      
Clinical and regulatory expenses $ 232   $ 83
Professional fees 1,183   2,157
Selling expenses 1,303   382
Manufacturing cost 4,541    
Other vendors 18   844
Total accounts payable 7,277   3,466
Accrued interest payable, related parties 42   842
Accrued interest payable 991   2,138
Accrued expenses:      
Payroll expenses 891   713
Government rebates and other rebates 1,355   933
Due to EJ Holdings 238   57
Other accrued expenses 704   86
Total accrued expenses 3,188   1,789
Total accounts payable and accrued expenses $ 11,498 $ 10,926 $ 8,235